ATIC

gene product
AICARFT, IMPCHASE, PURH
This gene encodes a bifunctional protein that catalyzes the last two steps of the de novo purine biosynthetic pathway. The N-terminal domain has phosphoribosylaminoimidazolecarboxamide formyltransferase activity, and the C-terminal domain has IMP cyclohydrolase activity. A mutation in this gene results in AICA-ribosiduria. [provided by RefSeq, Sep 2009]
More gene data

Featured antibodies

Antibodies

 

Filters

Application

Antibodypedia Validation Initiative

Validation method

Reference

Provider

Host

Reactivity

Antibody type

Conjugate

  or   Clear
Enhanced validation
Supportive data in Antibodypedia
Data presented on provider website
Data in Antibodypedia (inconclusive)
Recommended by provider
Validated within AVI
Eligible for validation within AVI
329 antibodies from 32 providers.

Antibody properties

General

Applications

or Cancel
AntibodyRefsTypeWBELICCIPIHCFC
Atlas Antibodies
1 antibody
GeneTex
5 antibodies
antibodies-online
123 antibodies
Novus Biologicals
9 antibodies
OriGene
14 antibodies
Biorbyt
14 antibodies
Aviva Systems Biology
5 antibodies
LifeSpan BioSciences, Inc.
50 antibodies
Invitrogen Antibodies
2 antibodies
Bioworld Technology, Inc
2 antibodies
NovoPro Bioscience Inc.
3 antibodies
Affinity Biosciences
1 antibody
Abnova Corporation
7 antibodies
Acris Antibodies GmbH
3 antibodies
Signalway Antibody LLC
1 antibody
Bethyl Laboratories
2 antibodies
ProSci
4 antibodies
RabMAbs
2 antibodies
Boster Biological Technology
2 antibodies
Proteintech Group
1 antibody
Arigo
1 antibody
BioLegend
1 antibody
United States Biological
37 antibodies
St John's Laboratory
4 antibodies
MyBioSource
6 antibodies
Creative Diagnostics
6 antibodies
RayBiotech, Inc.
2 antibodies
Sigma-Aldrich
4 antibodies
Exalpha Biologicals, Inc.
1 antibody
Abbexa
3 antibodies
Abgent
1 antibody